)
Shares of Aarti Drugs dipped 7% to Rs 688 on the BSE after the company reported a 14% year-on-year decline in net profit at Rs 18.86 crore for the fourth quarter ended March 31, 2015 (Q4), on account of lower sales. The pharmaceutical company had posted a profit of Rs 21.95 crore in the same quarter last year.
During the quarter, total operational income of the company declined 1.8% to Rs 278 crore as against Rs 283 crore in the corresponding quarter of the previous fiscal. The EBITDA or operating profit margins were flat at about 15% over the previous year's corresponding quarter.
The stock opened at Rs 698 and touched a low of Rs 676 on the BSE. Till 1048 hours, a combined 143,056 shares changed hands on the counter on the BSE and NSE.
Meanwhile, the stock is among the top performers from the BSE small-cap index in the current calendar year 2015. The stock has rallied 73% so far in 2015, from Rs 427 to Rs 739, compared to a 1% gain in the benchmark S&P BSE Sensex as of yesterday.
During the quarter, total operational income of the company declined 1.8% to Rs 278 crore as against Rs 283 crore in the corresponding quarter of the previous fiscal. The EBITDA or operating profit margins were flat at about 15% over the previous year's corresponding quarter.
The stock opened at Rs 698 and touched a low of Rs 676 on the BSE. Till 1048 hours, a combined 143,056 shares changed hands on the counter on the BSE and NSE.
Meanwhile, the stock is among the top performers from the BSE small-cap index in the current calendar year 2015. The stock has rallied 73% so far in 2015, from Rs 427 to Rs 739, compared to a 1% gain in the benchmark S&P BSE Sensex as of yesterday.
